Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 19/20 | 0.61 |
| ▸ | PIK3CG | P48736 | 17/20 | 0.56 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.46 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9954059 | 0.94 | PI4KA (0.64) | PI4KAPIK3CGPIK3CDPIK3CAPIK3CB | |
| SCHEMBL9954271 | 0.94 | PI4KA (0.68) | PI4KAPIK3CGPIK3CDPIK3CAPIK3CB | |
| SCHEMBL9953320 | 0.88 | PI4KA (0.57) | PI4KAPIK3CGPIK3CDPIK3CAPIK3CB | |
| SCHEMBL9954130 | 0.87 | PI4KA (0.62) | PI4KAPIK3CGPIK3CDPIK3CAPIK3CB | |
| SCHEMBL9960593 | 0.85 | PI4KA (0.62) | PI4KAPIK3CGPIK3CDPIK3CAPIK3CB | |
| SCHEMBL9954562 | 0.85 | PI4KA (0.61) | PI4KAPIK3CGPIK3CD | |
| SCHEMBL9954233 | 0.84 | PI4KA (0.55) | PI4KAPIK3CGPIK3CDPIK3CAPIK3CB | |
| SCHEMBL9954511 | 0.83 | PI4KA (0.64) | PI4KAPIK3CG | |
| SCHEMBL9954128 | 0.83 | PI4KA (0.64) | PI4KAPIK3CG | |
| SCHEMBL10288794 | 0.83 | PI4KA (0.61) | PI4KAPIK3CGPIK3CDPIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012087938-A1 | QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS | GLAXOSMITHKLINE LLC (US) | 2012-06-28 | — | — | WO | disclosed |
| WO-2012087938-A1 | QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS | GLAXOSMITHKLINE LLC (US) | 2012-06-28 | — | — | WO | disclosed |